xamoterol has been researched along with trimetrexate in 2 studies
Studies (xamoterol) | Trials (xamoterol) | Recent Studies (post-2010) (xamoterol) | Studies (trimetrexate) | Trials (trimetrexate) | Recent Studies (post-2010) (trimetrexate) |
---|---|---|---|---|---|
269 | 80 | 17 | 422 | 50 | 21 |
Protein | Taxonomy | xamoterol (IC50) | trimetrexate (IC50) |
---|---|---|---|
Dihydrofolate reductase | Mycobacterium avium | 0.3012 | |
Dihydrofolate reductase | Homo sapiens (human) | 0.0207 | |
Dihydrofolate reductase | Lacticaseibacillus casei | 0.1435 | |
Dihydrofolate reductase | Saccharomyces cerevisiae S288C | 0.042 | |
Dihydrofolate reductase | Escherichia coli K-12 | 0.1798 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.026 | |
Dihydrofolate reductase | Pneumocystis carinii | 0.0378 | |
Dihydrofolate reductase | Candida albicans | 0.04 | |
Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.01 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.008 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Toxoplasma gondii | 0.5788 | |
Bifunctional dihydrofolate reductase-thymidylate synthase | Trypanosoma cruzi | 0.0202 | |
Dihydrofolate reductase | Rattus norvegicus (Norway rat) | 0.0794 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
2 other study(ies) available for xamoterol and trimetrexate
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |